Exploring S-benzyl carbodithioates as urease inhibitors: synthesis, single crystal XRD, Hirshfeld surface analysis, enzyme inhibition and molecular modeling

•Crystal structure evaluation of two S-Benzyl Carbodithioates 1 and 2•Hirshfeld surface analysis•Computational studies of 1 and 2•Potential urease inhibitors•Docking studies against urease Two S-benzyl substituted carbodithioates –namely benzyl benzylmethylcarbamodithioate (1) and 4-(trifluoromethyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of molecular structure 2024-09, Vol.1311, p.138444, Article 138444
Hauptverfasser: Khan, Bilal Ahmad, Hamdani, Syeda Shamila, Jabeen, Aqsa, Ashfaq, Muhammad, Ahmed, Muhammad Naeem, Bogdanov, Georgii, Khushal, Aneela, Khan, Sara, Abdelrahim, Siham Khalaf Alla, Hassan, Abeer Ahmed
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Crystal structure evaluation of two S-Benzyl Carbodithioates 1 and 2•Hirshfeld surface analysis•Computational studies of 1 and 2•Potential urease inhibitors•Docking studies against urease Two S-benzyl substituted carbodithioates –namely benzyl benzylmethylcarbamodithioate (1) and 4-(trifluoromethyl)benzyl azepane-1-carbodithioate (2)– were synthesized by a single pot three-component reaction. Structures 1 and 2 were elucidated by means of FTIR, 1H-NMR, 13C-NMR, and single-crystal XRD analyses. Single crystal X-ray studies combined with Hirshfeld surface analysis manifestations outlined the opulent contributions of the intramolecular C-H⋯S interaction in stabilizing the molecular configuration of both compounds. Both carbodithioates under study showed encouraging indications for inhibition efficiency toward urease enzyme, with 1 (IC50 = 0.75 ± 0.04 μM) being more efficient than 2 (IC50 = 1.22 ± 0.02 μM), respectively. Docking computations revealed the binding modes of 1 and 2 with the targeted enzymes. The presented work would serve as a cornerstone for future investigations into potential new inhibitors for pharmaceutical and biological applications. [Display omitted]
ISSN:0022-2860
1872-8014
DOI:10.1016/j.molstruc.2024.138444